{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:18:49Z","timestamp":1790731129939,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1867,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1038\/modpathol.2017.88","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T07:40:47Z","timestamp":1501832447000},"page":"1720-1727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas"],"prefix":"10.1016","volume":"30","author":[{"given":"Lauren L","family":"Ritterhouse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Mino-Kenudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette M","family":"Sholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A John","family":"Iafrate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2017.88_bib1","doi-asserted-by":"crossref","first-page":"92ra66","DOI":"10.1126\/scitranslmed.3002543","article-title":"Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development","volume":"3","author":"Wu","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1038\/modpathol.2017.88_bib2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/j.gastro.2015.07.041","article-title":"A combination of molecular markers and clinical features improve the classification of pancreatic cysts","volume":"149","author":"Springer","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1038\/modpathol.2017.88_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.prp.2015.06.004","article-title":"A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix","volume":"211","author":"Hara","year":"2015","journal-title":"Pathol Res Pract"},{"key":"10.1038\/modpathol.2017.88_bib4","doi-asserted-by":"crossref","first-page":"e87966","DOI":"10.1371\/journal.pone.0087966","article-title":"GNAS mutations identify a set of right-sided, RAS mutant, villous colon cancers","volume":"9","author":"Fecteau","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1038\/modpathol.2017.88_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/den.12710","article-title":"Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms","volume":"29","author":"Kadayifci","year":"2017","journal-title":"Dig Endosc"},{"key":"10.1038\/modpathol.2017.88_bib6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/340692a0","article-title":"GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours","volume":"340","author":"Landis","year":"1989","journal-title":"Nature"},{"key":"10.1038\/modpathol.2017.88_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1126\/science.2116665","article-title":"Two G protein oncogenes in human endocrine tumors","volume":"249","author":"Lyons","year":"1990","journal-title":"Science"},{"key":"10.1038\/modpathol.2017.88_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.humpath.2015.01.005","article-title":"Novel molecular insights from routine genotyping of colorectal carcinomas","volume":"46","author":"Stachler","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2017.88_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/modpathol.2010.232","article-title":"Impact of proposed IASLC\/ATS\/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases","volume":"24","author":"Yoshizawa","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.88_bib10","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jtho.2016.03.011","article-title":"Prognosis in resected invasive mucinous adenocarcinomas of the lung: related factors and comparison with resected nonmucinous adenocarcinomas","volume":"11","author":"Lee","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1038\/modpathol.2017.88_bib11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/PAS.0000000000000246","article-title":"Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation","volume":"38","author":"Kadota","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.88_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1309\/550P-QLJX-D84W-F6DN","article-title":"Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies","volume":"116","author":"Goldstein","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.88_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1309\/UMF715KRG2V198YD","article-title":"Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma","volume":"122","author":"Saad","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.88_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/path.1947","article-title":"Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin","volume":"209","author":"Tsuta","year":"2006","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2017.88_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/jcp.2003.007138","article-title":"Thyroid transcription factor 1 in pulmonary adenocarcinoma","volume":"57","author":"Stenhouse","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2017.88_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.lungcan.2009.05.021","article-title":"Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib","volume":"68","author":"Wislez","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1038\/modpathol.2017.88_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1309\/AJCP62WJUAMSZCOM","article-title":"Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study","volume":"139","author":"Wu","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.88_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/hupa.2002.126876","article-title":"Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma","volume":"33","author":"Shah","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2017.88_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2353\/jmoldx.2007.060182","article-title":"Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features","volume":"9","author":"Finberg","year":"2007","journal-title":"J Mol Diagn"},{"key":"10.1038\/modpathol.2017.88_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1309\/WVXFGAFLAUX48DU6","article-title":"Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations","volume":"128","author":"Sakuma","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.88_bib21","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1002\/cncr.26010","article-title":"Clinicopathological features of lung adenocarcinoma with KRAS mutations","volume":"117","author":"Kakegawa","year":"2011","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2017.88_bib22","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.humpath.2013.05.026","article-title":"Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation","volume":"44","author":"Ichinokawa","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2017.88_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jtho.2016.01.010","article-title":"KRAS and NKX2-1 mutations in invasive mucinous adenocarcinoma of the lung","volume":"11","author":"Hwang","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1038\/modpathol.2017.88_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1158\/2159-8290.CD-13-0633","article-title":"CD74-NRG1 fusions in lung adenocarcinoma","volume":"4","author":"Fernandez-Cuesta","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1038\/modpathol.2017.88_bib25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1038\/modpathol.2017.88_bib26","doi-asserted-by":"crossref","first-page":"e87062","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"key":"10.1038\/modpathol.2017.88_bib27","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2017.88_bib28","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1038\/modpathol.2017.88_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1038\/modpathol.2017.88_bib30","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/ijc.22143","article-title":"Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features","volume":"119","author":"Buttitta","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2017.88_bib31","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/cncr.21853","article-title":"Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer","volume":"106","author":"Suzuki","year":"2006","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2017.88_bib32","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H","article-title":"Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung","volume":"92","author":"Ahrendt","year":"2001","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2017.88_bib33","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1158\/1078-0432.CCR-08-0646","article-title":"Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma","volume":"14","author":"Riely","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.88_bib34","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/JTO.0000000000000579","article-title":"Unique genetic and survival characteristics of invasive mucinous adenocarcinoma of the lung","volume":"10","author":"Shim","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1038\/modpathol.2017.88_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12967-016-0877-x","article-title":"GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study","volume":"14","author":"Pietrantonio","year":"2016","journal-title":"J Transl Med"},{"issue":"5","key":"10.1038\/modpathol.2017.88_bib36","doi-asserted-by":"crossref","first-page":"845-854.e1","DOI":"10.1016\/j.jamcollsurg.2014.11.029","article-title":"GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma","volume":"220","author":"Tan","year":"2015","journal-title":"Journal of the American College of Surgeons"},{"key":"10.1038\/modpathol.2017.88_bib37","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1038\/onc.2010.202","article-title":"The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min\/+) mice through activation of Wnt and ERK1\/2 MAPK pathways","volume":"29","author":"Wilson","year":"2010","journal-title":"Oncogene"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201788.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201788","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522201955X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522201955X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2017.88","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201788.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:55:09Z","timestamp":1760230509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522201955X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S089339522201955X"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2017.88","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.88","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}